Rini BI - Search Results

1

Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.

Vickers MM, Al-Harbi H, Choueiri TK, Kollmannsberger C, North S, MacKenzie M, Knox JJ, Rini BI, Heng DY. Vickers MM, et al. Among authors: rini bi. Clin Genitourin Cancer. 2013 Sep;11(3):311-5. doi: 10.1016/j.clgc.2013.04.012. Epub 2013 May 15. Clin Genitourin Cancer. 2013. PMID: 23684422

2

Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.

Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.

3

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.

Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ. Rini BI, et al. Cancer. 2004 Jul 1;101(1):90-5. doi: 10.1002/cncr.20313. Cancer. 2004. PMID: 15221993 Free article. Clinical Trial.

4

A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Small EJ. Rini BI, et al. Cancer. 2005 Feb 1;103(3):553-8. doi: 10.1002/cncr.20795. Cancer. 2005. PMID: 15612026 Free article. Clinical Trial.

5

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Dunlap S, Elchinoff A, Yu N, Bok R, Simko J, Small EJ. Rini BI, et al. Cancer. 2006 Feb 1;106(3):566-75. doi: 10.1002/cncr.21661. Cancer. 2006. PMID: 16369983 Free article. Clinical Trial.

6

SU11248 and AG013736: current data and future trials in renal cell carcinoma.

Rini BI. Rini BI. Clin Genitourin Cancer. 2005 Dec;4(3):175-80. doi: 10.3816/CGC.2005.n.029. Clin Genitourin Cancer. 2005. PMID: 16425985 Review.

7

Sunitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Motzer RJ, et al. Among authors: rini bi. JAMA. 2006 Jun 7;295(21):2516-24. doi: 10.1001/jama.295.21.2516. JAMA. 2006. PMID: 16757724 Clinical Trial.

8

Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports.

Shaheen PE, Rini BI, Bukowski RM. Shaheen PE, et al. Among authors: rini bi. Clin Genitourin Cancer. 2006 Jun;5(1):78-81. doi: 10.3816/CGC.2006.n.021. Clin Genitourin Cancer. 2006. PMID: 16859583

9

A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.

Stadler WM, Halabi S, Rini B, Ernstoff MS, Davila E, Picus J, Barrier R, Small EJ; Cancer and Leukemia Group B. Stadler WM, et al. Cancer. 2006 Sep 15;107(6):1273-9. doi: 10.1002/cncr.22117. Cancer. 2006. PMID: 16909426 Free article. Clinical Trial.

10

Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinoma.

Reddy GK, Mughal TI, Rini BI. Reddy GK, et al. Among authors: rini bi. Clin Genitourin Cancer. 2006 Sep;5(2):110-3. doi: 10.3816/cgc.2006.n.026. Clin Genitourin Cancer. 2006. PMID: 17026798 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters